This inventor holds 6 USPTO granted patents and 14 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignee: The Children's Hospital of Philadelphia. Active years: 2015-2022.
Location History:
- Turnersville, NJ (US) (2017)
- Mullica Hill, NJ (US) (2015 - 2022)
Company Filing History:
Years Active: 2015-2022
Title: Joseph Glessner: Innovator in Autism and ADHD Research
Introduction
Joseph Glessner is a distinguished inventor based in Mullica Hill, NJ, who has made significant contributions to the fields of neuroscience and pediatric healthcare. With a total of six patents to his name, Glessner's work focuses on innovative methods for diagnosing and treating cognitive disorders such as autism spectrum disorder and attention-deficit hyperactivity disorder (ADHD).
Latest Patents
Among his most recent patents, Glessner's methods for diagnosing and treating autism are noteworthy. He has developed techniques that allow for the identification of autism spectrum disorder through the detection of copy number variations (CNVs) in an mGluR network gene within patient samples. For patients presenting with these CNVs, Glessner's research highlights an effective treatment involving (+)-5-oxo-D-prolinepiperidinamide monohydrate (NS-105). Furthermore, his work on ADHD encompasses both compositions and methodologies aimed at the detection and treatment of the disorder, bringing much-needed advancements to this area of pediatric healthcare.
Career Highlights
Joseph Glessner is currently affiliated with The Children's Hospital of Philadelphia, where he continues to engage in groundbreaking research. His work not only impacts the lives of children diagnosed with cognitive disorders but also contributes to the broader medical community's understanding of these conditions.
Collaborations
Throughout his career, Glessner has collaborated with esteemed colleagues, including Hakon Hakonarson and Jordan Orange, enhancing the depth and reach of his research. These professional partnerships underline the collaborative nature of innovation in the medical field, fostering advancements that can lead to better patient outcomes.
Conclusion
Joseph Glessner's innovative contributions to the diagnosis and treatment of autism and ADHD mark him as a prominent figure in the field of pediatric healthcare. With six patents and ongoing research efforts, he continues to pave the way for future advancements that may significantly improve the quality of life for children and their families.